NDAINJECTIONINJECTABLE
Approved
Jun 1987
Lifecycle
LOE Approaching
Competitive Pressure
30/100
Data completeness
2/8 — Basic
CIS-PYRO (technetium tc99m pyrophosphate) by PharmaIN is radiopharmaceutical activity [moa]. First approved in 1987.
Drug data last refreshed 20h ago · AI intelligence enriched 2w ago
AI summarySynthesized from FDA + DailyMed + ClinicalTrials.gov data
CIS-PYRO is a radiopharmaceutical diagnostic agent containing Technetium TC99M bound to pyrophosphate, used for nuclear imaging procedures. It functions as a radioactive tracer that accumulates in target tissues, enabling visualization of cardiac, bone, and other organ pathology through gamma camera imaging. The drug has been in clinical use since 1987 and represents a foundational imaging modality in nuclear medicine.
LOE Approaching
Product approaching loss of exclusivity with moderate competitive pressure; team focus likely shifting toward lifecycle management and cost optimization rather than growth initiatives.
Mechanism of Action
Radiopharmaceutical Activity
Pharmacologic Class:
Radioactive Diagnostic Agent
Indications
Indication data is being enriched from DailyMed and FDA labeling. Check back soon for approved therapeutic uses.
Career Relevance
Working on CIS-PYRO offers exposure to legacy product management, lifecycle strategy, and operational excellence in a mature diagnostic franchise. Career growth may be limited by the product's stable trajectory, but roles offer deep expertise in radiopharmaceutical commercialization and manufacturing.
Product ManagerCommercial Operations
Worked on CIS-PYRO at PharmaIN? Share your interview experience or compensation data (+7 days Pro)
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.